Bull Harbor Capital LLC Invests $835,000 in Cigna Group $CI

Bull Harbor Capital LLC purchased a new stake in shares of Cigna Group (NYSE:CI) during the first quarter, HoldingsChannel reports. The institutional investor purchased 3,131 shares of the health services provider’s stock, valued at approximately $835,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Strategic Investment Advisors MI bought a new stake in shares of Cigna Group in the 1st quarter worth $313,000. Arkadios Wealth Advisors boosted its position in shares of Cigna Group by 10.7% during the first quarter. Arkadios Wealth Advisors now owns 12,612 shares of the health services provider’s stock valued at $3,364,000 after buying an additional 1,219 shares during the last quarter. Opal Capital LLC boosted its position in shares of Cigna Group by 19.3% during the first quarter. Opal Capital LLC now owns 25,801 shares of the health services provider’s stock valued at $6,882,000 after buying an additional 4,178 shares during the last quarter. Amundi increased its holdings in Cigna Group by 31.0% in the 1st quarter. Amundi now owns 1,550,003 shares of the health services provider’s stock worth $413,464,000 after buying an additional 366,753 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in Cigna Group by 106.9% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,112 shares of the health services provider’s stock worth $830,000 after buying an additional 1,608 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported second-quarter adjusted earnings of $7.78 per share, above the roughly $7.58–$7.60 analyst consensus and up from $7.20 a year earlier. Total revenue rose 7% year over year to approximately $71.7 billion. Cigna Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its 2026 adjusted income-from-operations outlook to at least $30.45 per share, modestly above the previous outlook and analyst expectations. Growth across both Cigna Healthcare and Evernorth Health Services supported the increase. Cigna raises annual profit forecast
• Positive Sentiment: Cigna Healthcare adjusted revenue increased 9%, while Evernorth revenue rose 6%, indicating broad-based operating momentum. The company also repurchased about $250 million of stock year to date through July 29. The Cigna Group Reports Strong Second Quarter 2026 Results
• Neutral Sentiment: Cigna posted quarterly net income of nearly $1.7 billion, or $6.29 per share, but reported revenue slightly below the consensus estimate in some measures, highlighting the importance of adjusted results and segment growth.
• Negative Sentiment: Investors remain concerned about elevated pharmacy costs and management’s expectation for slower growth in prescriptions for popular GLP-1 drugs, which could limit near-term benefit from the fast-growing treatment category. Cigna Expects Lower Growth in GLP-1 Prescriptions
• Negative Sentiment: Reported data also shows significant insider selling during the past six months, including sales by Chairman and CEO David Cordani. While these transactions may reflect personal portfolio decisions, they can weigh on investor sentiment.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Mizuho raised their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Jefferies Financial Group lowered their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Wolfe Research restated an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Wells Fargo & Company lifted their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Price Performance

NYSE CI opened at $287.56 on Friday. The company has a 50-day moving average price of $286.75 and a 200-day moving average price of $281.12. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $76.07 billion, a P/E ratio of 12.19, a PEG ratio of 1.14 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Insiders Place Their Bets

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.